> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Posts 1st Quarter Drug Safety Evaluations
- URL: https://www.fdaweb.com/fda-posts-1st-quarter-drug-safety-evaluations/
- Published: 2016-04-14T12:00:00.000Z
- Updated: 2026-09-14T20:54:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5135369

> FDA has posted the results of five drug safety evaluations completed between 10/1 and 12/31/15\. For four of the five — Wyeth’s Duavee (conjugated estrogens/bazedoxifene) tablet, film-coated; Medicis’ Luzu (luliconazole) cream; zoledronic acid injection; and Iroko’s Zorvolex (diclofenac) capsule — no new safety issues were identified through the evaluations. FDA says it is continuing to evaluate the potential safety issue of weight gain identified in Takeda’s Brintellix (vorioxetine) tablet, film-coated, to determine if regulatory action is required.